GlassScriptPhysician profile
Halei Wong
NPI 1952613283
$6,190.28
in general payments reported to CMS, 2019-2025
11 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 77% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $340 · 2021: $1,988 · 2022: $1,691 · 2023: $248 · 2024: $188 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396 · Travel and Lodging: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.80 |
| Travel and Lodging | $426.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,709.81 | 2019-2025 | |
| Intuitive Surgical, INC. | $1,559.11 | 2021-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $1,346.50 | 2021-2025 | Interstim |
| Axonics, INC. | $215.57 | 2021-2024 | Axonics |
| Medtronic USA, INC. | $108.26 | 2020 | |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Boston Scientific Corporation | $69.59 | 2019-2025 | Axonics |
| Hologic Sales and Service, LLC | $26.05 | 2024 | Acessa Provu System |
| Organon LLC | $20.85 | 2024 | |
| Merck Sharp & Dohme LLC | $20.82 | 2025 | Keytruda |
| Astellas Pharma US INC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Halei Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.